Katarzyna Klonowska

765 citations

20 papers · 452 indexed · h-index 12

Co-authors: Piotr Kozłowski David J. Kwiatkowski Catherine L. Salussolia Mustafa Şahin Marek Figlerowicz Malwina Suszyńska Marzena Anna Lewandowska Anna J. Jasinska
Topics: Cancer Genomics and Diagnostics (9 papers)Tuberous Sclerosis Complex Research (6 papers)BRCA gene mutations in cancer (4 papers)
Cited by: Cancer Research Genetics Physiology
Journals: PLoS ONE Scientific Reports Clinical Cancer Research
Partner nations: Poland United States United Kingdom

In The Last Decade

Katarzyna Klonowska

18 papers receiving 449 citations

Peers

Countries citing papers authored by Katarzyna Klonowska

Since Specialization

Citations

This map shows the geographic impact of Katarzyna Klonowska's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Katarzyna Klonowska with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Katarzyna Klonowska more than expected).

Fields of papers citing papers by Katarzyna Klonowska

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Katarzyna Klonowska. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Katarzyna Klonowska. The network helps show where Katarzyna Klonowska may publish in the future.

Co-authorship network of co-authors of Katarzyna Klonowska

This figure shows the co-authorship network connecting the top 25 collaborators of Katarzyna Klonowska. A scholar is included among the top collaborators of Katarzyna Klonowska based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Katarzyna Klonowska. Katarzyna Klonowska is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Implementation of the Finnish Good Practice “Smart Family” in Poland 2025 ·Children ·(unknown),(unknown),(unknown),Katarzyna Klonowska,(unknown),(unknown),(unknown),(unknown),Päivi Mäki,(unknown),(unknown),(unknown)	0
2	Comprehensive genetic and phenotype analysis of 95 individuals with mosaic tuberous sclerosis complex 2023 ·The American Journal of Human Genetics ·Katarzyna Klonowska,Krinio Giannikou,(unknown),(unknown),Aaron R. Thorner,Zachary T. Herbert,(unknown),(unknown),Lana Hamieh,Katarzyna Kotulska,Sergiusz Jóźwiak,Joel Moss,Thomas N. Darling,David J. Kwiatkowski	19
3	Mild TSC phenotype and non-penetrance associated with a frameshift variant in TSC2 prompts caution in evaluating pathogenicity of frameshift variants 2023 ·Gene ·Laura S. Farach,Hope Northrup,Mark Nellist,Leontine van Unen,(unknown),Katarzyna Klonowska,Rosemary Ekong,Peter B. Crino,Kit Sing Au	3
4	TSC2 inactivation, low mutation burden and high macrophage infiltration characterise hepatic angiomyolipomas 2023 ·Histopathology ·Krinio Giannikou,Katarzyna Klonowska,Junko Tsuji,Shulin Wu,(unknown),Clemens K. Probst,Katrina Kao,Chin‐Lee Wu,Scott J. Rodig,Adrián Mariño‐Enríquez,Yoh Zen,Inga‐Marie Schaefer,David J. Kwiatkowski	2
5	Phase II Clinical Trial of Everolimus in a Pan-Cancer Cohort of Patients with mTOR Pathway Alterations 2021 ·Clinical Cancer Research ·Elio Adib,Katarzyna Klonowska,Krinio Giannikou,T. Khanh,(unknown),(unknown),(unknown),(unknown),(unknown),Lynette M. Sholl,Junko Tsuji,David M. Hyman,(unknown),Geoffrey I. Shapiro,Hebert Alberto Vargas,James J. Harding,Martin H. Voss,Gopa Iyer,David J. Kwiatkowski	37
6	Performance of In Silico Prediction Tools for the Detection of Germline Copy Number Variations in Cancer Predisposition Genes in 4208 Female Index Patients with Familial Breast and Ovarian Cancer 2021 ·Cancers ·(unknown),(unknown),Britta Blümcke,(unknown),Malwina Suszyńska,(unknown),Julika Borde,Katarzyna Klonowska,Barbara Wappenschmidt,Jan Hauke,Piotr Kozłowski,Rita K. Schmutzler,Eric Hahnen,Corinna Ernst	6
7	Sporadic facial angiofibroma and sporadic angiomyolipoma mimicking tuberous sclerosis complex 2021 ·Journal of Medical Genetics ·Katarzyna Klonowska,Elizabeth A. Thiele,(unknown),Aaron R. Thorner,David J. Kwiatkowski	1
8	Large-scale meta-analysis of mutations identified in panels of breast/ovarian cancer-related genes — Providing evidence of cancer predisposition genes 2019 ·Gynecologic Oncology ·Malwina Suszyńska,Katarzyna Klonowska,Anna J. Jasinska,Piotr Kozłowski	49
9	Primary Health Care PLUS project in Poland: disease management programs 2019 ·International Journal of Integrated Care ·(unknown),(unknown),Katarzyna Klonowska,(unknown),(unknown),Magdalena Bogdan,(unknown),Marcin Czech,Donata Kurpas,Andrzej Śliwczyński	0
10	Genetic Etiologies, Diagnosis, and Treatment of Tuberous Sclerosis Complex 2019 ·Annual Review of Genomics and Human Genetics ·Catherine L. Salussolia,Katarzyna Klonowska,David J. Kwiatkowski,Mustafa Şahin	105
11	BARD1 is a Low/Moderate Breast Cancer Risk Gene: Evidence Based on an Association Study of the Central European p.Q564X Recurrent Mutation 2019 ·Cancers ·Malwina Suszyńska,Wojciech Kluźniak,Dominika Wokołorczyk,Anna Jakubowska,Tomasz Huzarski,Jacek Gronwald,Tadeusz Dębniak,Marek Szwiec,Magdalena Ratajska,Katarzyna Klonowska,Steven A. Narod,Natalia Bogdanova,Thilo Dörk,Jan Lubiński,Cezary Cybulski,Piotr Kozłowski	25
12	Germline loss-of-function variants in the BARD1 gene are associated with familial breast cancer 2018 ·Senologie - Zeitschrift für Mammadiagnostik und -therapie ·Nana Weber‐Lassalle,Julika Borde,Konstantin Weber‐Lassalle,(unknown),Guido Neidhardt,Corinna Ernst,Britta Blümcke,Katarzyna Klonowska,Alexander E. Volk,Christian Kubisch,Ronny Baber,Christoph Engel,Piotr Kozłowski,Eric Hahnen,Rita K. Schmutzler,Jan Hauke	2
13	The 30 kb deletion in the APOBEC3 cluster decreases APOBEC3A and APOBEC3B expression and creates a transcriptionally active hybrid gene but does not associate with breast cancer in the European population 2017 ·Oncotarget ·Katarzyna Klonowska,Wojciech Kluźniak,(unknown),Anna Jakubowska,Magdalena Ratajska,(unknown),(unknown),(unknown),Marzena Wojciechowska,Cezary Cybulski,Jan Lubiński,Piotr Kozłowski	25
14	MTTE: an innovative strategy for the evaluation of targeted/exome enrichment efficiency 2016 ·Oncotarget ·Katarzyna Klonowska,Luiza Handschuh,(unknown),Marek Figlerowicz,Piotr Kozłowski	3
15	The Use of a Two-Tiered Testing Strategy for the Simultaneous Detection of Small EGFR Mutations and EGFR Amplification in Lung Cancer 2015 ·PLoS ONE ·Marzena Anna Lewandowska,(unknown),Katarzyna Klonowska,Wojciech Jóźwicki,Janusz Kowalewski,Piotr Kozłowski	27
16	Analysis of large mutations in BARD1 in patients with breast and/or ovarian cancer: the Polish population as an example 2015 ·Scientific Reports ·Katarzyna Klonowska,Magdalena Ratajska,(unknown),(unknown),Izabela Brożek,Magdalena Koczkowska,Marcin Śniadecki,Jarosław Dębniak,Dariusz Wydra,(unknown),Maciej Stukan,Agnieszka Żmieńko,Beata Nowakowska,Irmgard Irminger‐Finger,Janusz Limon,Piotr Kozłowski	24
17	Cancer predisposing BARD1 mutations affect exon skipping and are associated with overexpression of specific BARD1 isoforms 2015 ·Oncology Reports ·Magdalena Ratajska,Magdalena Matusiak,(unknown),Bartosz Wasąg,Izabela Brożek,Wojciech Biernat,Magdalena Koczkowska,Jarosław Dębniak,Marcin Śniadecki,Piotr Kozłowski,Katarzyna Klonowska,Maxim Pilyugin,Dariusz Wydra,Geoff Laurent,Janusz Limon,Irmgard Irminger‐Finger	15
18	Oncogenomic portals for the visualization and analysis of genome-wide cancer data 2015 ·Oncotarget ·Katarzyna Klonowska,(unknown),Marzena Wojciechowska,Luiza Handschuh,Agnieszka Żmieńko,Marek Figlerowicz,Hanna Dams‐Kozlowska,Piotr Kozłowski	43
19	High copy number variation of cancer-related microRNA genes and frequent amplification ofDICER1andDROSHAin lung cancer 2015 ·Oncotarget ·(unknown),Marzena Anna Lewandowska,Katarzyna Klonowska,Krzysztof Roszkowski,Janusz Kowalewski,Marek Figlerowicz,Piotr Kozłowski	55
20	An MLPA-based approach for high-resolution genotyping of disease-related multi-allelic CNVs 2014 ·Gene ·(unknown),Katarzyna Klonowska,Marek Figlerowicz,Piotr Kozłowski	11

About Katarzyna Klonowska

Katarzyna Klonowska is a scholar working on Cancer Research, Physiology and Pathology and Forensic Medicine, having authored 20 papers that have together received 452 indexed citations. Recurring topics across this work include Cancer Genomics and Diagnostics (9 papers), Tuberous Sclerosis Complex Research (6 papers) and BRCA gene mutations in cancer (4 papers). The work is most often cited by research in Cancer Research (122 citations), Genetics (134 citations) and Physiology (104 citations). Katarzyna Klonowska has collaborated with scholars based in Poland, United States and United Kingdom. Frequent co-authors include Piotr Kozłowski, David J. Kwiatkowski, Catherine L. Salussolia, Mustafa Şahin, Marek Figlerowicz, Malwina Suszyńska, Marzena Anna Lewandowska, Anna J. Jasinska, Janusz Kowalewski and Krzysztof Roszkowski. Their work appears in journals such as PLoS ONE, Scientific Reports and Clinical Cancer Research.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact